Actively Recruiting
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
Led by University of Miami · Updated on 2026-04-09
100
Participants Needed
2
Research Sites
180 weeks
Total Duration
On this page
Sponsors
U
University of Miami
Lead Sponsor
B
Beauty of Sight
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the study is to determine the safety and efficacy of brief intraoperative corneal endothelial graft incubation in plasma rich in growth factors (PRGF) for reducing postoperative endothelial cell loss.
CONDITIONS
Official Title
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing endothelial keratoplasty (DSEK or DMEK) at Bascom Palmer Eye Institute or Price Vision Group
- Using corneal graft tissue preserved within 14 days
You will not qualify if you...
- History of corneal transplantation in the study eye
- Best corrected visual acuity worse than 20/40 in the opposite eye
- Systemic immunosuppression
- Previous intraocular surgeries other than cataract surgery, such as glaucoma tubes or silicone oil
- Adults unable to give consent
- Pregnant women
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Bascom Palmer Eye Institute
Miami, Florida, United States, 33136
Actively Recruiting
2
Price Vision Group
Indianapolis, Indiana, United States, 46260
Actively Recruiting
Research Team
A
Alfonso L Sabater, MD
CONTACT
M
Marianne Price, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here